Candida Infections Prophylaxis in Hematopoietic Stem Cell Transplantation Recipients
📧 Sign up to get email alerts when something new happens for Candida Infections Prophylaxis in Hematopoietic Stem Cell Transplantation Recipients.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-06-27FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., expanding labeling through a supplem…